BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3923383)

  • 1. Effects of a thyrotropin releasing hormone analogue on locomotor and other motor activity in the rat.
    Clarke KA; Parker AJ
    Neuropeptides; 1985 Apr; 6(2):101-12. PubMed ID: 3923383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further studies on the effects of a thyrotropin releasing hormone analogue on locomotor activity in the rat.
    Clarke KA; Parker AJ
    Neuropeptides; 1986; 8(2):99-109. PubMed ID: 3093913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral profile of the TRH analogue RX77368 in developing rats.
    Jackson HC
    Peptides; 1990; 11(5):897-901. PubMed ID: 2126622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a thyrotrophin-releasing hormone analogue, RX77368, on AMPA-induced septal-hippocampal lesioned rats in an operant delayed non-matching to position test.
    Ballard TM; Hunter AJ; Bennett GW
    Psychopharmacology (Berl); 1996 Oct; 127(3):265-75. PubMed ID: 8912405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyrotropin releasing hormone (TRH) and a degradation stabilized analogue (RX77368) stimulate phosphoinositide turnover in cultured astrocytes in a regionally specific manner.
    McDermott AM; Dickinson SL; Wilkin GP
    Neurochem Int; 1992 Apr; 20(3):307-13. PubMed ID: 1338971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of locomotion in neonate rats by TRH analogue CG3703.
    Clarke KA; Kirby K
    Neuropeptides; 1994 Jan; 26(1):71-5. PubMed ID: 8159287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The TSH, T4, T3 and prolactin responses to consecutive infusions of a potent and stabilized thyrotrophin releasing hormone analogue, RX77368, in man.
    Eckland DJ; Lightman SL
    Eur J Clin Invest; 1988 Aug; 18(4):405-9. PubMed ID: 2844546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRH analogue affects information transfer through the ventrobasal thalamus.
    Clarke KA
    Neuropeptides; 1986 Jan; 7(1):31-9. PubMed ID: 3081829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyrotropin-releasing hormone analogue and serotonin interact within the dorsal vagal complex to augment gastric acid secretion.
    McTigue DM; Rogers RC; Stephens RL
    Neurosci Lett; 1992 Sep; 144(1-2):61-4. PubMed ID: 1436715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the locomotor effects induced by centrally injected TRH and TRH analogues.
    Sharp T; Bennett GW; Marsden CA; Tulloch IF
    Regul Pept; 1984 Nov; 9(4):305-15. PubMed ID: 6441196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motoneurone excitability after administration of a thyrotrophin releasing hormone analogue.
    Clarke KA; Stirk G
    Br J Pharmacol; 1983 Nov; 80(3):561-5. PubMed ID: 6416344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological and biochemical comparison of thyrotropin releasing hormone (TRH) and di-methyl proline-TRH on pituitary GH3 cells.
    McDermott AM; Wilkin GP; Dickinson SL
    Br J Pharmacol; 1990 Nov; 101(3):615-20. PubMed ID: 1963801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motoneurone excitability during antidromically evoked inhibition after administration of a thyrotrophin releasing hormone (TRH) analogue.
    Clarke KA; Parker AJ; Stirk GC
    Neuropeptides; 1984 Sep; 4(5):403-11. PubMed ID: 6436727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the motor behaviours produced by the intrathecal administration of thyrotrophin-releasing hormone and thyrotrophin-releasing hormone analogues in the conscious rat.
    Johnson JV; Fone KC; Havler ME; Tulloch IF; Bennett GW; Marsden CA
    Neuroscience; 1989; 29(2):463-70. PubMed ID: 2498761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyrotropin-releasing hormone (TRH) acts centrally to stimulate gastric contractility in rats.
    Garrick T; Buack S; Veiseh A; Tache Y
    Life Sci; 1987 Feb; 40(7):649-57. PubMed ID: 3100898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiological observations in patients with motor neuron disease receiving a thyrotropin releasing hormone analogue (RX77368).
    Guiloff RJ; Stålberg E; Eckland DJ; Lightman SL
    J Neurol Neurosurg Psychiatry; 1987 Dec; 50(12):1633-40. PubMed ID: 3125307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological activity of TRH thionalogue and its diastereoisomers.
    Alexandrová M; Strbák V; Herman ZS; Stachura Z; Kruszyński M
    Endocrinol Exp; 1987 Mar; 21(1):43-9. PubMed ID: 3106009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of motoneurone excitability by combined administration of 5-HT agonist and TRH analogue.
    Clarke KA; Parker AJ; Stirk GC
    Neuropeptides; 1985 Jun; 6(3):269-82. PubMed ID: 3160967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal substance P and galanin attenuate TRH analogue-induced wet-dog shake behaviour.
    Dixon DM; Fone KC; Bennett GW; Marsden CA
    Br J Pharmacol; 1989 Dec; 98 Suppl():829P. PubMed ID: 2482111
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of a radioimmunoassay for RX77368 (pGlu-His-3,3-dimethyl proline amide)--a stable analogue of thyrotrophin releasing hormone (TRH).
    Lynn AG; Bennett GW
    J Pharm Biomed Anal; 1991; 9(1):9-18. PubMed ID: 1904280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.